On June 2, Wedbush analyst Liana Moussatos published a list of upcoming catalysts for emerging pharmaceuticals, specifically for Intercept Pharmaceuticals Inc (NASDAQ:ICPT), Receptos …
Omeros Corporation (NASDAQ:OMER), a biopharmaceutical company committed to discovering, developing and commercializing both small-molecule and protein therapeutics for large-market as well as orphan indications …
In a research report issued today, MLV analyst Raghuram Selvaraju reiterated a Buy rating on Omeros Corporation (NASDAQ:OMER) with a price target of $38, after the company …
In a research report issued this morning, Maxim Group analyst Jason Kolbert reiterated a Buy rating on Omeros Corporation (NASDAQ:OMER) and slightly raised the price …
